14
results
for author:"Ligon A.H."
in Literature Citations
| FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Nucera C., Eeckhoute J., Finn S., Carroll J.S., Ligon A.H., Priolo C., Fadda G., Toner M., Sheils O., Attard M. et al. Clin. Cancer Res. 15:3680-3689(2009) · Mapped (2) |
| CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Firestein R., Bass A.J., Kim S.Y., Dunn I.F., Silver S.J., Guney I., Freed E., Ligon A.H., Vena N., Ogino S. et al. Nature 455:547-551(2008) · Mapped (4) |
| A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors. Yeh I.T., Lenci R.E., Qin Y., Buddavarapu K., Ligon A.H., Leteurtre E., Do Cao C., Cardot-Bauters C., Pigny P., Dahia P.L. Hum. Genet. 124:279-285(2008) · Mapped (6) |
| Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Chiang D.Y., Villanueva A., Hoshida Y., Peix J., Newell P., Minguez B., LeBlanc A.C., Donovan D.J., Thung S.N., Sole M. et al. Cancer Res. 68:6779-6788(2008) · Mapped (7) |
| Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Schuller U., Heine V.M., Mao J., Kho A.T., Dillon A.K., Han Y.G., Huillard E., Sun T., Ligon A.H., Qian Y. et al. Cancer Cell 14:123-134(2008) · Mapped (23) |
| Disruption of chromodomain helicase DNA binding protein 2 (CHD2) causes scoliosis. Kulkarni S., Nagarajan P., Wall J., Donovan D.J., Donell R.L., Ligon A.H., Venkatachalam S., Quade B.J. Am. J. Med. Genet. A 146A:1117-1127(2008) · Mapped (3) |
| NFIA haploinsufficiency is associated with a CNS malformation syndrome and urinary tract defects. Lu W., Quintero-Rivera F., Fan Y., Alkuraya F.S., Donovan D.J., Xi Q., Turbe-Doan A., Li Q.G., Campbell C.G., Shanske A.L. et al. PLoS Genet. 3:e80-e80(2007) · Mapped (22) |
| Disruption of diacylglycerol kinase delta (DGKD) associated with seizures in humans and mice. Leach N.T., Sun Y., Michaud S., Zheng Y., Ligon K.L., Ligon A.H., Sander T., Korf B.R., Lu W., Harris D.J. et al. Am. J. Hum. Genet. 80:792-799(2007) · Mapped (4) |
| Disruption of a synaptotagmin (SYT14) associated with neurodevelopmental abnormalities. Quintero-Rivera F., Chan A., Donovan D.J., Gusella J.F., Ligon A.H. Am. J. Med. Genet. A 143:558-563(2007) · Mapped (4) |
| HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies. Gross K.L., Neskey D.M., Manchanda N., Weremowicz S., Kleinman M.S., Nowak R.A., Ligon A.H., Rogalla P., Drechsler K., Bullerdiek J. et al. Genes Chromosomes Cancer 38:68-79(2003) · Mapped (10) |
| Human chromosome 7: DNA sequence and biology. Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R. et al. Science 300:767-772(2003) · UniProtKB (658) |
| ORC5L, a new member of the human origin recognition complex, is deleted in uterine leiomyomas and malignant myeloid diseases. Quintana D.G., Thome K.C., Hou Z.-H., Ligon A.H., Morton C.C., Dutta A. J. Biol. Chem. 273:27137-27145(1998) · UniProtKB (2) · Mapped (2) |
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Steck P.A., Pershouse M.A., Jasser S.A., Lin H., Yung W.K.A., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T. et al. |
| Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma. Ligon A.H., Pershouse M.A., Jasser S.A., Yung W.K.A., Steck P.A. Oncogene 14:1075-1081(1997) · UniProtKB (1) |
